Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.

Cutis; cutaneous medicine for the practitioner

Volumn 67, Issue 6 Suppl, 2001, Pages 4-9

  Webster, G F ^a   Berson, D ^a   Stein, L F ^a   Fivenson, D P ^a   Tanghetti, E A ^a   Ling, M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATOLYTIC AGENT; NICOTINIC ACID DERIVATIVE; RETINOIC ACID; RETINOID; TAZAROTENE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GEL; HUMAN; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMANS; KERATOLYTIC AGENTS; MALE; NICOTINIC ACIDS; RETINOIDS; TREATMENT OUTCOME; TRETINOIN;

EID: 0035380538     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)